Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized TrialsSabino De Placido, Giuseppe Cancello, Diego D’Agostino et al.|Journal of Clinical Oncology|2007Cited by 413
Outcome of special types of luminal breast cancerMarco Colleoni, Giulia Viale, Giuseppe Cancello et al.|Annals of Oncology|2011Cited by 123
Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancerGiuseppe Cancello, Emilia Montagna, Diego D’Agostino et al.|Breast Cancer Research|2008Cited by 59
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapyEmilia Montagna, Marco Colleoni, Vincenzo Bagnardi et al.|Annals of Oncology|2014Cited by 54
Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncologyMichelino De Laurentiis, Sabino De Placido, Giuseppe Cancello et al.|Annals of Oncology|2005Cited by 49